News | March 08, 2022
Industry upbeat on biopharma sector
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
The speakers for the e-conference are: Dr. Mukund Chorgade, President/CSO, THINQ Pharma; Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance; Jayaseelan J., National Vice President (Industry Division), Indian Pharmaceutical Association; Spandan Mishra who is Director- Sales, Customer Service & Logistics for Evonik India, Nepal & Sri Lanka region; Dr. Kommu Nagaiah, Chief Scientist & Head, CSIR-IICT; Govind K. Jaju, Partner, Suingora Consulting; nd Pravin Prashant, Executive Editor, Indian Pharma Post & Editor, Indian Chemical News.
Biosynthetic Technologies produces estolides, a new class of biobased synthetic oils used in a number of applications, including motor oil, industrial lubricants, pharmaceuticals, and personal care.
UCB plans to submit regulatory applications in Q3 2022
This is the company’s first partnership arrangement in China
Industry Report highlights the opportunities and need for multiple sectoral collaboration through 12 actionable recommendations under 6 thematic areas
EMBER500RNA Prestain Loading Dye allows single-step denaturing, loading, and bright RNA staining on regular agarose gels
She replaces Victoria Tabiner, who is stepping down after 10 years at Sygnature
This collaborative nursing conference generated a positive dialogue on how the healthcare space of nursing has evolved in the past year
It is estimated that one-third of our country’s population has some form of these disorders
Subscribe To Our Newsletter & Stay Updated
